Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03468218 |
|---|---|
| Brief Title: | Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer |
| First Submitted : | March 10, 2018 |
| First Submitted that Met QC Criteria : | March 10, 2018 |
| First Posted : | March 16, 2018 |
| Last Update Submitted that Met QC Criteria : | May 6, 2023 |
| Last Update Posted : | May 9, 2023 |